Quoin Pharmaceuticals (QNRX) Market Capitalization (2017 - 2026)

Quoin Pharmaceuticals has disclosed Market Capitalization across 10 years of filings, most recently posting $457041.2 for Q2 2026.

• In Q2 2026, Market Capitalization rose 152.56% year-over-year to $457041.2; the TTM figure through Jun 2026 stood at $457041.2 (up 152.56% YoY), while the FY2025 annual figure was $513780.2, down 85.57% from the prior year.
• Market Capitalization came in at $457041.2 for Q2 2026 at Quoin Pharmaceuticals, down from $622815.6 in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $156.2 million in Q1 2022 to a low of $140967.1 in Q3 2025.
• Average Market Capitalization over 5 years is $16.7 million, with a median of $3.5 million recorded in 2024.
• Year-over-year, Market Capitalization tumbled 100.0% in 2022 and jumped 306.47% in 2026.
• Over 5 years, Market Capitalization stood at $48.1 million in 2022, then plunged by 88.27% to $5.6 million in 2023, then sank by 36.98% to $3.6 million in 2024, then slumped by 85.57% to $513780.2 in 2025, then dropped by 11.04% to $457041.2 in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $457041.2 in Q2 2026, $622815.6 in Q1 2026, and $513780.2 in Q4 2025.